In vitro activities of new 2-substituted quinolines against Leishmania donovani. 2011

Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
Groupe Chimiothérapie Antiparasitaire, UMR 8076 CNRS BioCis, Faculté de Pharmacie, Université Paris-Sud, 92290-Châtenay-Malabry, France. philippe.loiseau@u-psud.fr

A series of 9 quinolines and 18 styrylquinolines was evaluated for the drugs' in vitro antileishmanial activities and cytotoxicities. The 7-aroylstyrylquinoline scaffold appeared to be the most promising one, with the most interesting compound, no. 35, exhibiting a 50% inhibitory concentration (IC(50)) of 1.2 μM and a selectivity index value of 121.5. Compound 35 was 10-fold and 8-fold more active than miltefosine and sitamaquine, the reference compounds, with selectivity indexes 607-fold and 60-fold higher, respectively.

UI MeSH Term Description Entries
D007893 Leishmania donovani A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (Leishmania) donovani,Leishmania leishmania donovani,Leishmania donovanus,Leishmania leishmania donovanus,donovani, Leishmania leishmania,donovanus, Leishmania,donovanus, Leishmania leishmania,leishmania donovanus, Leishmania
D011804 Quinolines
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
May 2002, Pharmacology,
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
March 2005, Farmaco (Societa chimica italiana : 1989),
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
December 2014, Planta medica,
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
June 2021, Molecules (Basel, Switzerland),
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
July 1997, The Journal of antimicrobial chemotherapy,
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
February 1993, Indian journal of experimental biology,
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
January 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
January 2001, Pharmacology,
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
November 2007, Phytotherapy research : PTR,
Philippe M Loiseau, and Suman Gupta, and Aditya Verma, and Saumya Srivastava, and S K Puri, and Faten Sliman, and Marie Normand-Bayle, and Didier Desmaele
September 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Copied contents to your clipboard!